Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16,192 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
[Comparison of clinical efficacy between first-generation and second-generation tyrosine kinase inhibitors based regimen in the treatment of patients with BCR-ABL positive acute lymphoblastic leukemia].
Liu Y, Mi RH, Chen L, Yuan FF, Yin QS, Fu YW, Zhu XH, Liu XJ, Zhang YL, Zhang WL, Wei XD. Liu Y, et al. Among authors: wei xd. Zhonghua Xue Ye Xue Za Zhi. 2019 Sep 14;40(9):738-743. doi: 10.3760/cma.j.issn.0253-2727.2019.09.005. Zhonghua Xue Ye Xue Za Zhi. 2019. PMID: 31648474 Free PMC article. Chinese.
[Combination of interferon alpha-1b, interleukin-2 and thalidomide as maintenance therapy on acute myeloid leukemia patients with negative minimal residual disease].
Chen L, Li GP, Mi RH, Yuan FF, Ai H, Wang Q, Wang ZF, Wang GJ, Fan RH, Yin QS, Wei XD. Chen L, et al. Among authors: wei xd. Zhonghua Xue Ye Xue Za Zhi. 2020 Sep 14;41(9):766-769. doi: 10.3760/cma.j.issn.0253-2727.2020.09.011. Zhonghua Xue Ye Xue Za Zhi. 2020. PMID: 33113610 Free PMC article. Chinese. No abstract available.
16,192 results
You have reached the last available page of results. Please see the User Guide for more information.